Actionable news
0
All posts from Actionable news
Actionable news in ARWR: Arrowhead Research Corporation,

Arrowhead Pharmaceuticals to Present at Upcoming Conferences

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) will make presentations at the following upcoming events:

“RNA interference (RNAi) with ARC-AAT provides deep and prolonged knockdown of alpha-1 antitrypsin levels in healthy volunteers”

Tweet this

The 25th Annual Credit Suisse Healthcare Conference – Scottsdale, AZ, November 6-8, 2016

November 7, 11:30 a.m. MST – Christopher Anzalone, Ph.D., Arrowhead president and CEO will deliver a corporate presentation

The Liver Meeting® 2016, the Annual Meeting of the American Association for the Study of Liver Disease (AASLD) – Boston, November 11-15, 2016

November 13, 5:30 p.m. EST – Christine Wooddell, Ph.D., Arrowhead director of liver targeting will deliver an oral presentation titled, “RNA interference therapeutic ARC-AAT prevents production of Z-alpha1 antitrypsin polymers and reverses liver disease phenotype in PiZ mouse model

November 13, 8:00 a.m. EST – Alice Turner, MBChB (Hons), MRCP, PGCE (MedEd), PhD, University of Birmingham, Edgbaston Birmingham, United Kingdom, and coauthors, will deliver a late-breaking poster presentation titled, “RNA interference (RNAi) with ARC-AAT provides deep and prolonged knockdown of alpha-1 antitrypsin levels in healthy volunteers

American Heart Association’s Scientific Sessions 2016 – New Orleans, November 12-16, 2016

November 14, 10:40 a.m. CST – Stacey Melquist, Ph.D., Arrowhead senior scientist will deliver an oral presentation titled, “Targeting factor XII (F12) with a novel RNAi delivery platform as a prophylactic treatment for thromboembolism

November 14, 2:00 p.m. CST – Stacey Melquist, Ph.D., Arrowhead senior scientist will deliver an oral presentation titled, “Targeting apolipoprotein(a) with a novel RNAi delivery platform as a prophylactic treatment to reduce risk of cardiovascular events in individuals with elevated lipoprotein (a)

The 28th Annual Piper Jaffray Healthcare Conference – New York, November 29-30, 2016

November 30, 8:30 a.m. EST – Christopher Anzalone, Ph.D., Arrowhead president and CEO will deliver a corporate overview in a fireside chat with Ted Tenthoff, senior research analyst, Piper Jaffray

Copies of presentation materials and webcasts can be accessed on the Events and Presentations page under the Investors section of the Arrowhead website after...


More